Alder Biopharmaceuticals Inc. Secures $11,100,000 Series A Round

  • Feed Type
  • Date
  • Company Name
    Alder Biopharmaceuticals Inc.
  • Mailing Address
    11804 North Creek Parkway South Bothell, WA 98011
  • Company Description
    Alder Biopharmaceuticals uniquely identifies, develops, and manufactures novel antibody therapeutics to alleviate human suffering in the autoimmune and inflammatory disease areas. Alder’s management team combines decades of industry experience with a proven track record for identifying and developing novel antibody therapeutics.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    This funding will allow us to develop our lead antibody therapeutic, broaden our product pipeline, and build on our proprietary antibody discovery and manufacturing technologies.
  • M&A Terms
  • Venture Investor
    Sevin Rosen Funds
  • Venture Investor
    Ventures West
  • Venture Investor
    WRF Capital

Trending on Xconomy